![Leigh Hsu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Leigh Hsu
Corporate Officer/Principal bei CARSGEN THERAPEUTICS HOLDINGS LIMITED
Aktive Positionen von Leigh Hsu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CARSGEN THERAPEUTICS HOLDINGS LIMITED | Corporate Officer/Principal | 01.06.2017 | - |
Karriereverlauf von Leigh Hsu
Ehemalige bekannte Positionen von Leigh Hsu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | - | - |
Lpath, Inc.
![]() Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 19.02.2013 | - |
Ausbildung von Leigh Hsu
University of California San Diego | Doctorate Degree |
University of California, Irvine | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 5 |
China | 2 |
Operativ
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CARSGEN THERAPEUTICS HOLDINGS LIMITED | Health Technology |
ACADIA PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Lpath, Inc.
![]() Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |